Effect of probiotic treatment relative to placebo (mean; 99% CI) | |||||
---|---|---|---|---|---|
Probiotic group (mean ± SD) | Placebo group (mean ± SD) | Ratio | Difference | Qualitative inference | |
Males | |||||
Number of episodes | 1.01 ± 1.70 | 0.49 ± 0.90 | 2.06; 0.51 to 11 | Likely ↑ | |
Duration (d) | 3.3 ± 5.8 | 1.3 ± 7.7 | 2.57: 0.53 to 17 | Likely ↑ | |
Severity (1-3 scale) | 1.31 ± 0.33 | 1.78 ± 0.73 | -0.47; -1.21 to 0.28 | Possible ↓ | |
Symptom Load (severity-days) | 4.4 ± 8.1 | 2.5 ± 5.8 | 1.76; 0.34 to 15 | Possible ↑ | |
Females | |||||
Number of episodes | 1.44 ± 1.71 | 0.48 ± 0.71 | 3.02; 0.76 to 17 | Likely ↑ | |
Duration (d) | 3.9 ± 5.4 | 2.1 ± 4.3 | 1.85; 0.35 to 27 | Possible ↑ | |
Severity (1-3 scale) | 1.44 ± 0.68 | 1.75 ± 0.88 | -0.31; -1.39 to 0.79 | Possible ↓ | |
Symptom Load (severity-days) | 5.2 ± 7.08 | 2.9 ± 5.1 | 1.81; 0.37 to 24 | Possible ↑ |